Santen Pharmaceutical Co(JP:4536)
¥2,085.50+50.50 (+2.48%)
JP:4536
Santen Pharmaceutical Co earnings date
¥2,085.50
At close:+50.50 (+2.48%)
Want to see JP:4536 full AI Analyst Report?
Santen Pharmaceutical Co (4536) Q2 2026 Earnings Report
1 Followers
JP:4536 Q2 2026 EPS Results
- Actual EPS
- JPY 25.67
- Consensus EPS
- JPY 31.24
- Beat/Miss
- Missed by -JPY 5.57
- One Year Ago EPS
- JPY 24.44
JP:4536 Q2 2026 Revenue Results
- Actual Revenue
- JPY 74.33B
- Expected Revenue
- JPY 72.80B
- Beat/Miss
- Beat by +JPY 1.54B
- YoY Revenue Growth
- +7.51%
Earnings Announcement Details
- Quarter
- Q2 2026
- Date
- 11/05/2026
- Time
- TBA
- Conference Call
- Thursday, November 5, 2026
JP:4536 Upcoming Earnings
Santen Pharmaceutical Co's next earnings date is estimated for February 9, 2027, based on past reporting schedules.
Q2 2026 Earnings Call Audio
JP:4536 Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
No earnings call summary is available for this earnings event.
JP:4536 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Feb 09, 2027 | 2026 (Q3) | 37.63- | 24.4 | ― | ― |
| Nov 05, 2026 | 2026 (Q2) | 31.2425.67 | 24.44 | 5.03% (+1.23) | |
| Aug 06, 2026 | 2026 (Q1) | 21.2722.38 | 17.32 | 29.21% (+5.06) | |
| May 12, 2026 | 2025 (Q4) | 30.7947.88 | 25.77 | 85.80% (+22.11) | |
| Feb 05, 2026 | 2025 (Q3) | 29.2924.40 | 25.33 | -3.67% (-0.93) | |
| Nov 06, 2025 | 2025 (Q2) | 20.8924.44 | 23.29 | 4.94% (+1.15) | |
| Aug 07, 2025 | 2025 (Q1) | 23.9017.32 | 29.59 | -41.47% (-12.27) | |
| May 13, 2025 | 2024 (Q4) | 17.3025.77 | 16.38 | 57.30% (+9.39) | |
| Feb 06, 2025 | 2024 (Q3) | 26.1125.33 | 20.2 | 25.40% (+5.13) | |
| Nov 07, 2024 | 2024 (Q2) | 21.6923.29 | 24.13 | -3.48% (-0.84) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed


